- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07578883
Scar Mobilization Improves Scars and Quality of Life in Burned Children.
Effects of the Scar Tissue Mobilization on Scar Thickness, Pliability and Quality of Life in Children With Upper Extremity Burns.
Studieoversikt
Detaljert beskrivelse
Burn injuries, especially to the upper extremities, are common in children and can lead to hypertrophic scarring, resulting in pain, stiffness, and reduced range of motion. These complications significantly impact a child's ability to perform daily activities and affect overall quality of life and development. Rehabilitation plays a vital role in recovery, with scar tissue mobilization being a key intervention to improve scar flexibility and function. While commonly used, there is limited evidence on its specific effects in pediatric upper limb burns. This study aims to assess the impact of scar tissue mobilization on scar thickness, pliability and quality of life in children with upper extremity burns.
The study design will be Quasi experimental study. The data will be collected from mayo hospital, Lahore. The study will be completed in 10 months after the approval of synopsis. Children aged 8 to 13 years old will be included in this study and each patient will receive the same intervention. The participants will receive scar tissue mobilization intervention for 15 minutes twice a week for 5 weeks. Participants fulfilling the eligibility criteria will be asked to assign the consent form before entering into the study. The scar thickness and pliability will be measure from the Vancouver Scar Scale (VSS) and quality of life with Brisbane Scar Impact Profile (BBSIP). The synopsis will be presented to Research Ethical Committee of Riphah International University, Lahore for ethical approval to conduct this study. Data will be analyzed through SPSS 27.
Studietype
Registrering (Antatt)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
- Navn: IMRAN AMJAD, PhD
- Telefonnummer: 9233224390125
- E-post: IMRAN.AMJAD@RIPHAH.EDU.PK
Studer Kontakt Backup
- Navn: Muhammad Asif Javed, MS-PT
- Telefonnummer: 9233224209422
- E-post: a.javed@riphah.edu.pk
Studiesteder
-
-
Punjab Province
-
Lahore, Punjab Province, Pakistan, 54000
- Rekruttering
- Mayo Hospital
-
Ta kontakt med:
- IMRAN AMJAD, PhD
- Telefonnummer: 9233224390125
- E-post: IMRAN.AMJAD@RIPHAH.EDU.PK
-
Ta kontakt med:
- Muhammad Asif Javed, MS-PT
- Telefonnummer: 923224209422
- E-post: a.javed@riphah.edu.pk
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
Tar imot friske frivillige
Beskrivelse
Inclusion Criteria:
- 8-13 years
- Stable scar and referred for scar management
- Affected upper extremity joints (shoulder, elbow and wrist) with burned injuries
- Partial thickness and full thickness burn.
Exclusion Criteria:
- Pre-existing skin condition or allergies
- Neurological disorders affecting motor function
- Fracture with burn in upper limbs
- Patient with only superficial burns
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Annen
- Tildeling: N/A
- Intervensjonsmodell: Enkeltgruppeoppdrag
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Scar Tissue Mobilization on Scars and Quality of Life in Pediatric Upper Extremity Burns
Patients received 15-minute massage sessions twice weekly for 5 weeks by the same therapist.
Techniques included moderate-pressure strokes around wounds.
|
15-minute massage twice weekly for 5 weeks using baby oil by the same therapist.
Included moderate-pressure strokes, finger pressing, circular movements, skin rolling, and finishing gliding strokes.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
vancouver scar scale
Tidsramme: Baseline, 5 week
|
The Vancouver Scar Scale (VSS) is a widely used semi-quantitative tool for scar assessment that evaluates four parameters: vascularity, pigmentation, pliability, and height/thickness.
It has a total score range of 0-13/14, where 0 indicates normal skin and higher scores represent more severe scarring, including thick scars and contractures.
|
Baseline, 5 week
|
|
Brisbane burn scar impact profile (BBSIP)
Tidsramme: Baseline, 5 week
|
A 40-item scale assessing children's quality of life across domains such as daily activities, hand function, appearance, psychological status, social relationships, and school activities.
Items are scored from 0 (not at all) to 4 (a lot), with total scores classified as good (40-80), fair (80-100), and poor (>100).
A 58-item burn scar-specific HRQoL self-report tool covering 10 domains including sensory, mobility, daily living, social interaction, appearance, and emotional reactions.
Items use dichotomous, 11-point, or 5-point Likert scales; scores are calculated per domain, with lower scores indicating better quality of life.
|
Baseline, 5 week
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Areej Saher, MS-PT, Riphah International University
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Antatt)
Studiet fullført (Antatt)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- REC/RCR&AHS/24/Areej Saher
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .